UK drug exports to US spared tariffs under deal critics say will cost NHS billions
#UK #US #drug exports #tariffs #NHS #trade deal #pharmaceuticals #costs
📌 Key Takeaways
- UK drug exports to the US will be exempt from tariffs under a new trade agreement.
- Critics argue the deal will cost the UK's National Health Service billions of pounds.
- The agreement aims to protect pharmaceutical trade between the UK and US.
- Concerns focus on potential negative financial impacts on the NHS.
📖 Full Retelling
<p>‘Partnership’ on drug pricing also gives patients in Britain greater access to potentially life-extending treatments </p><p>British drug exports to the US will escape tariffs imposed by Donald Trump as part of a controversial UK-US medicines deal that critics fear will mean less money for the NHS.</p><p>The deal will also give patients in Britain greater access to potentially life-extending drugs because the rules have been relaxed to allow the NHS to pay more fo
🏷️ Themes
Trade Agreement, Healthcare Costs
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
<p>‘Partnership’ on drug pricing also gives patients in Britain greater access to potentially life-extending treatments </p><p>British drug exports to the US will escape tariffs imposed by Donald Trump as part of a controversial UK-US medicines deal that critics fear will mean less money for the NHS.</p><p>The deal will also give patients in Britain greater access to potentially life-extending drugs because the rules have been relaxed to allow the NHS to pay more fo
Read full article at source